title: Individualizing therapy for pancreatic cancer.
authors.forename: Emily K
authors.initials: EK
authors.lastname: Colvin
authors.forename: David K
authors.initials: DK
authors.lastname: Chang
authors.forename: Neil D
authors.initials: ND
authors.lastname: Merrett
authors.forename: James G
authors.initials: JG
authors.lastname: Kench
authors.forename: Andrew V
authors.initials: AV
authors.lastname: Biankin
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis*; D018395:CA-19-9 Antigen / Q000032:analysis; D006801:Humans; D008207:Lymphatic Metastasis; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D020932:Nerve Growth Factor / Q000032:analysis; D010190:Pancreatic Neoplasms / Q000737:chemistry / Q000473:pathology / Q000628:therapy*; D018579:Patient Selection; D011237:Predictive Value of Tests; D020917:Receptor, trkA / Q000032:analysis; D012008:Recurrence; D016896:Treatment Outcome
chemical_list: D014408:Biomarkers, Tumor; D018395:CA-19-9 Antigen; D020932:Nerve Growth Factor; D020917:Receptor, trkA